País: Espanya
Idioma: anglès
Font: HMA (Heads of Medicines Agencies)
apramycin sulfate 100 g/kg
Huvepharma N.V.
QJ01GB90
Premix for medicated feed
apramycin
Pigs
2013-05-29
1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Apravet 100 g/kg premix for medicated feeding stuff for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Each kg contains: Apramycin sulfate 100 g, equivalent to apramycin 100.000.000 IU For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Premix for medicated feeding stuff Granular powder 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of bacterial enteritis caused by micro-organisms susceptible to apramycin such as _Escherichia coli. _ 4.3 CONTRAINDICATIONS Do not use in the cases of hypersensitivity to apramycin Do not use in cats 4.4 SPECIAL WARNINGS The uptake of medication by animals can be altered as a consequence of illness. In case of insufficient uptake of feed animals should be treated parenterally. The use of the product should be combined with good management practices e.g. good hygiene, proper ventilation, no overstocking. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use of the product should be based on susceptibility testing and should take into account official national and regional policies. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the apramycin and may decrease the effectiveness of treatment with aminoglycosides due to the potential for crossresistance SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS 3 Wash h Llegiu el document complet
1 SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Apravet 100 g/kg premix for medicated feeding stuff for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Each kg contains: Apramycin sulfate 100 g, equivalent to apramycin 100.000.000 IU For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Premix for medicated feeding stuff Granular powder 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of bacterial enteritis caused by micro-organisms susceptible to apramycin such as _Escherichia coli. _ 4.3 CONTRAINDICATIONS Do not use in the cases of hypersensitivity to apramycin Do not use in cats 4.4 SPECIAL WARNINGS The uptake of medication by animals can be altered as a consequence of illness. In case of insufficient uptake of feed animals should be treated parenterally. The use of the product should be combined with good management practices e.g. good hygiene, proper ventilation, no overstocking. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use of the product should be based on susceptibility testing and should take into account official national and regional policies. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the apramycin and may decrease the effectiveness of treatment with aminoglycosides due to the potential for crossresistance SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS 3 Wash h Llegiu el document complet